Long-circulating perfluorooctyl bromide nanocapsules for tumor imaging by 19FMRI

Biomaterials

Volumn 33, Issue 22, 2012, Pages 5593-5602

  Diou, Odile ^a,b   Tsapis, Nicolas ^a,b   Giraudeau, Céline ^c   Valette, Julien ^c,d   Gueutin, Claire ^a,b   Bourasset, Fanchon ^e   Zanna, Sandrine ^b   Vauthier, Christine ^a,b   Fattal, Elias ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b CNRS   (France)

^c CEA SACLAY   (France)

^d INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

19F MRI; EPR effect; Nanocapsules; PEGylation; PFOB

Indexed keywords

BLOOD STREAMS; CONTRAST AGENT; CORE-SHELL MORPHOLOGIES; ENCAPSULATION EFFICIENCY; ENHANCED PERMEATION AND RETENTIONS; EPR EFFECT; IN-VITRO; INTRAVENOUS INJECTIONS; LIQUID CORES; PEGYLATION; PERFLUOROOCTYL BROMIDE; PFOB; PHYSICOCHEMICAL PROPERTY; RESIDENCE TIME; TRANSMISSION ELECTRON MICROSCOPY TEM; TUMOR IMAGING; ZETA POTENTIAL MEASUREMENTS;

BLOCK COPOLYMERS; BROMINE COMPOUNDS; CHEMICAL PROPERTIES; EMULSIFICATION; ENCAPSULATION; MAMMALS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOTOELECTRONS; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; TUMORS; X RAY PHOTOELECTRON SPECTROSCOPY; ZETA POTENTIAL;

NANOCAPSULES;

NANOCAPSULE; PERFLUOROOCTYL BROMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FEMALE; FLUORINE NUCLEAR MAGNETIC RESONANCE; IN VITRO STUDY; KINETICS; LIGHT SCATTERING; MOUSE; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; X RAY PHOTOELECTRON SPECTROSCOPY;

ANIMALS; CELL LINE, TUMOR; COLONIC NEOPLASMS; CONTRAST MEDIA; FEMALE; FLUOROCARBONS; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; NANOCAPSULES; PARTICLE SIZE;

MUS;

EID: 84861220844     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.04.037     Document Type: Article

References (54)

1. Shaffer T.H., Wolfson M.R. Liquid ventilation: an alternative ventilation strategy for management of neonatal respiratory distress. Eur J Pediatr 1996, 155(Suppl. 2):S30-S34.
2. Castro C.I., Briceno J.C. Perfluorocarbon-based oxygen carriers: review of products and trials. Artif Organs 2010, 34(8):622-634.
3. Diaz-Lopez R., Tsapis N., Santin M., Bridal S.L., Nicolas V., Jaillard D., et al. The performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agent. Biomaterials 2010, 31(7):1723-1731.
4. Mattrey R.F., Brown J.J., Shelton R.E., Ogino M.T., Johnson K.K., Mitten R.M. Use of perfluorooctylbromide (PFOB) to detect liver abscesses with computed tomography. safety and efficacy. Invest Radiol 1991, 26(9):792-798.
5. Wootton S.L., Coley B.D., Hilton S.V., Edwards D.K., Amberg J.R., Mattrey R.F. Value of brominated fluorocarbons for the radiographic diagnosis of small-bowel obstruction - comparison with other contrast agents in rats. Am J Roentgenol 1993, 161(2):409-416.
6. Gao Z., Kennedy A.M., Christensen D.A., Rapoport N.Y. Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics 2008, 48(4):260-270.
7. Ahrens E.T., Flores R., Xu H., Morel P.A. In vivo imaging platform for tracking immunotherapeutic cells. Nat Biotechnol 2005, 23(8):983-987.
8. Waters E.A., Chen J., Allen J.S., Zhang H., Lanza G.M., Wickline S.A. Detection and quantification of angiogenesis in experimental valve disease with integrin-targeted nanoparticles and 19-fluorine MRI/MRS. J Cardiovasc Magn Reson 2008, 10:43.
9. Srinivas M., Cruz L.J., Bonetto F., Heerschap A., Figdor C.G., de Vries I.J. Customizable, multi-functional fluorocarbon nanoparticles for quantitative in vivo imaging using 19F MRI and optical imaging. Biomaterials 2010, 31(27):7070-7077.
10. Giraudeau C., Flament J., Marty B., Boumezbeur F., Meriaux S., Robic C., et al. A new paradigm for high-sensitivity F-19 magnetic resonance imaging of perfluorooctylbromide. Magn Reson Med 2010, 63(4):1119-1124.
11. Giraudeau C., Djemai B., Ghaly M.A., Boumezbeur F., Meriaux S., Robert P., et al. High sensitivity (19) F MRI of a perfluorooctyl bromide emulsion: application to a dynamic biodistribution study and oxygen tension mapping in the mouse liver and spleen. NMR Biomed 2012, 25(4):654-660.
12. 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla. Invest Radiol 2006, 41(3):305-312.
13. Pisani E., Fattal E., Paris J., Ringard C., Rosilio V., Tsapis N. Surfactant dependent morphology of polymeric capsules of perfluorooctyl bromide: influence of polymer adsorption at the dichloromethane-water interface. J Colloid Interf Sci 2008, 326(1):66-71.
14. Pisani E., Tsapis N., Galaz B., Santin M., Berti R., Taulier N., et al. Perfluorooctyl bromide polymeric capsules as dual contrast agents for ultrasonography and magnetic resonance imaging. Adv Funct Mater 2008, 18(19):2963-2971.
15. Pamula E., Kokoszka J., Cholewa-Kowalska K., Laczka M., Kantor L., Niedzwiedzki L., et al. Degradation, bioactivity, and osteogenic potential of composites made of PLGA and two different sol-gel bioactive glasses. Ann Biomed Eng 2011, 39(8):2114-2129.
16. Wang L.S., Zhang Z.P., Chen H.C., Zhang S.L., Xiong C.D. Preparation and characterization of biodegradable thermoplastic elastomers (PLCA/PLGA blends). J Polym Res 2010, 17(1):77-82.
17. Dhar S., Gu F.X., Langer R., Farokhzad O.C., Lippard S.J. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci USA 2008, 105(45):17356-17361.
18. Gomez-Gaete C., Tsapis N., Besnard M., Bochot A., Fattal E. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles. Int J Pharm 2007, 331(2):153-159.
19. Park J., Fong P.M., Lu J., Russell K.S., Booth C.J., Saltzman W.M., et al. PEGylated PLGA nanoparticles for the improved delivery of doxorubicin. Nanomedicine 2009, 5(4):410-418.
20. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D.A., Torchilin V.P., et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 1995, 55(17):3752-3756.
21. Labarre D., Vauthier C., Chauvierre C., Petri B., Muller R., Chehimi M.M. Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. Biomaterials 2005, 26(24):5075-5084.
22. Lemarchand C., Gref R., Passirani C., Garcion E., Petri B., Muller R., et al. Influence of polysaccharide coating on the interactions of nanoparticles with biological systems. Biomaterials 2006, 27(1):108-118.
23. Gref R., Domb A., Quellec P., Blunk T., Muller R.H., Verbavatz J.M., et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev 1995, 16(2-3):215-233.
24. Nobs L., Buchegger F., Gurny R., Allemann E. Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods. Int J Pharm 2003, 250(2):327-337.
25. Calvo P., Gouritin B., Chacun H., Desmaele D., D'Angelo J., Noel J.P., et al. Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery. Pharm Res 2001, 18(8):1157-1166.
26. Diaz-Lopez R., Libong D., Tsapis N., Fattal E., Chaminade P. Quantification of pegylated phospholipids decorating polymeric microcapsules of perfluorooctyl bromide by reverse phase HPLC with a charged aerosol detector. J Pharm Biomed Anal 2008, 48(3):702-707.
27. Diaz-Lopez R., Tsapis N., Libong D., Chaminade P., Connan C., Chehimi M.M., et al. Phospholipid decoration of microcapsules containing perfluorooctyl bromide used as ultrasound contrast agents. Biomaterials 2009, 30(8):1462-1472.
28. Dalwadi G., Sunderland V.B. Purification of PEGylated nanoparticles using tangential flow filtration (TFF). Drug Dev Ind Pharm 2007, 33(9):1030-1039.
29. Mosbach E.H., Abel L.L., Kendall F.E. The effect of excess dietary cholesterol on the bile acid and sterol excretion. Trans N Y Acad Sci 1954, 16(3):156.
30. Kazatchkine M.D., Hauptmann G., Nydegger U.E. Techniques du complément 1986, INSERM, Paris.
31. Vauthier C., Persson B., Lindner P., Cabane B. Protein adsorption and complement activation for di-block copolymer nanoparticles. Biomaterials 2011, 32(6):1646-1656.
32. Pisani E., Tsapis N., Paris J., Nicolas V., Cattel L., Fattal E. Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: physical characterization. Langmuir 2006, 22(9):4397-4402.
33. Sanson C., Schatz C., Le Meins J.F., Brulet A., Soum A., Lecommandoux S. Biocompatible and biodegradable poly(trimethylene carbonate)-b-poly(L-glutamic acid) polymersomes: size control and stability. Langmuir 2010, 26(4):2751-2760.
34. Tressaud A., Haufe G. Fluorine and health: molecular imaging, biomedical materials and pharmaceuticals 2008, Elsevier Science.
35. Pisani E., Ringard C., Nicolas V., Raphael E., Rosilio V., Moine L., et al. Tuning microcapsules surface morphology using blends of homo- and copolymers of PLGA and PLGA-PEG. Soft Matter 2009, 5(16):3054-3060.
36. Child P., Rafter J. Calcium enhances the hemolytic action of bile salts. Biochim Biophys Acta 1986, 855(3):357-364.
37. Ilani A., Granoth R. The pH dependence of the hemolytic potency of bile salts. Biochim Biophys Acta 1990, 1027(2):199-204.
38. Essa S., Rabanel J.M., Hildgen P. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles. Eur J Pharm Biopharm 2010, 75(2):96-106.
39. Zweers M.L., Engbers G.H., Grijpma D.W., Feijen J. In vitro degradation of nanoparticles prepared from polymers based on DL-lactide, glycolide and poly(ethylene oxide). J Control Release 2004, 100(3):347-356.
40. Jeong J.H., Lim D.W., Han D.K., Park T.G. Synthesis, characterization and protein adsorption behaviors of PLGA/PEG di-block co-polymer blend films. Colloids Surf B Biointerfaces 2000, 18(3-4):371-379.
41. Shakesheff K.M., Evora C., Soriano I., Langer R. The adsorption of poly(vinyl alcohol) to biodegradable microparticles studied by x-ray photoelectron spectroscopy (XPS). J Colloid Interf Sci 1997, 185(2):538-547.
42. Dong Y.C., Feng S.S. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Biomaterials 2004, 25(14):2843-2849.
43. Vittaz M., Bazile D., Spenlehauer G., Verrecchia T., Veillard M., Puisieux F., et al. Effect of PEO surface density on long-circulating PLA-PEO nanoparticles which are very low complement activators. Biomaterials 1996, 17(16):1575-1581.
44. Law S.K., Dodds A.W. The internal thioester and the covalent binding properties of the complement proteins C3 and C4. Protein Sci 1997, 6(2):263-274.
45. Moghimi S.M., Andersen A.J., Ahmadvand D., Wibroe P.P., Andresen T.L., Hunter A.C. Material properties in complement activation. Adv Drug Deliv Rev 2011, 63(12):1000-1007.
46. Arima Y., Kawagoe M., Furuta M., Toda M., Iwata H. Effect of swelling of poly(vinyl alcohol) layers on complement activation. Biomaterials 2010, 31(27):6926-6933.
47. Vonarbourg A., Passirani C., Saulnier P., Simard P., Leroux J.C., Benoit J.P. Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. J Biomed Mater Res A 2006, 78(3):620-628.
48. Demoy M., Andreux J.P., Weingarten C., Gouritin B., Guilloux V., Couvreur P. Spleen capture of nanoparticles: influence of animal species and surface characteristics. Pharm Res 1999, 16(1):37-41.
49. Texbook of small animal surgery 2002, Elsevier. D. Slatter (Ed.).
50. Lacava L.M., Lacava Z.G.M., Azevedo R.B., Chaves S.B., Garcia V.A.P., Silva O., et al. Use of magnetic resonance to study biodistribution of dextran-coated magnetic fluid intravenously administered in mice. J Magn Magn Mater 2002, 252(1-3):367-369.
51. Brattain M.G., Strobel-Stevens J., Fine D., Webb M., Sarrif A.M. Establishment of mouse colonic carcinoma cell lines with different metastatic properties. Cancer Res 1980, 40(7):2142-2146.
52. Beatty G.L., Paterson Y. IFN-gamma can promote tumor evasion of the immune system in vivo by down-regulating cellular levels of an endogenous tumor antigen. J Immunol 2000, 165(10):5502-5508.
53. Lu P.L., Chen Y.C., Ou T.W., Chen H.H., Tsai H.C., Wen C.J., et al. Multifunctional hollow nanoparticles based on graft-diblock copolymers for doxorubicin delivery. Biomaterials 2011, 32(8):2213-2221.
54. Oyewumi M.O., Yokel R.A., Jay M., Coakley T., Mumper R.J. Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. J Control Release 2004, 95(3):613-626.